StackTerminal.Health

BETA

Aniracetam

Aniracetam is a fat-soluble racetam that modulates AMPA receptors & has anxiolytic properties, potentially enhancing creativity, mood, & memory, particularly under stress.

cognitiveanxietymemorymood
Evidence last reviewed: 05 Apr 2026
Biomarkers studied
Outcomes directly measured across the evidence records below
Cognitive
Cognitive Function
Evidence
4 records
cognitive-function
patients with senile dementia of Alzheimer typeRCT
PUBMEDLow

Aniracetam was part of a symptomatic treatment that showed efficacy in improving cognitive dysfunction.

Dose: 1500 mg
pharmacokinetics
healthy Chinese male volunteersCohort
PUBMEDModerate

The pharmacokinetics of aniracetam showed a Tmax of 0.4 hours & a Cmax of approximately 8.7 ng/mL.

Dose: 400 mgForm: CapsuleTiming: single-dose
cognitive-function
subjects with chronic psychosyndrome after long-term exposure to organic solventsRCT
PUBMEDLow

No significant changes in neuropsychological symptoms were observed with aniracetam treatment.

Dose: 1000 mgDuration: 3 monthsForm: Capsule
cognitive-function
elderly patients with mild to moderate cognitive impairmentRCT
PUBMEDModerate

Aniracetam showed significant improvement in psychobehavioural parameters compared to placebo.

Dose: 1000 mgDuration: 6 monthsForm: Capsule
Forms
Capsule
Commonly available in 750 mg capsules.
Powder
Can be mixed with liquids for easier consumption.

Stacks containing Aniracetam

Public community stacks that include this ingredient.

Explore all stacks →
cognitivemoodfocus

Aniracetam & bacopa monnieri are combined to support cognitive function & enhance mood. Aniracetam is known for its anxiolytic & cognitive-enhancing effects, while bacopa monnieri supports memory & reduces anxiety.

Aniracetam
1000mg
Bacopa Monnieri
300mg
New
View